IGF2BP1 and hepatocellular carcinoma: Furthermore, a study using HCC revealed that IGF2BP1 knockdown can remarkedly increase the infiltration of immune cells, including CD8+ T cells, CD4+ T cells, F4/80+ macrophage, and CD56+ natural killer cells, thereby decreasing PD-L1 expression level and activating tumor immune microenvironment.